Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.
about
Hepatitis C genotype 4: The past, present, and futureHepatitis C in human immunodeficiency virus co-infected individuals: Is this still a "special population"?The Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the LiteratureOutcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantationBarriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a reviewPreconception and contraceptive care for women living with HIVCoinfection with Hepatitis C Virus and Human Immunodeficiency Virus: Virological, Immunological, and Clinical OutcomesProteomic analyses of the effects of drugs of abuse on monocyte-derived mature dendritic cellsTreat Early or Wait and Monitor? A Qualitative Analysis of Provider Hepatitis C Virus Treatment Decision-Making in the Context of HIV CoinfectionHepatitis C.Enhancing our understanding of current therapies for hepatitis C virus (HCV)Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersPotential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected PatientsInitiation of antiretroviral therapy.Seroprevalence of hepatitis C virus among people living with HIV/AIDS in Latin America and the Caribbean: a systematic reviewOutcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfectionTreatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.Treatment of chronic hepatitis C in HIV-infected patients with compensated liver cirrhosis.HIV induces TRAIL sensitivity in hepatocytesReal-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort.Meta-analysis: increased mortality associated with hepatitis C in HIV-infected persons is unrelated to HIV disease progression.Intravenous drug use - an independent predictor for HCV genotypes 3 and 4 infection among HIV/HCV co-infected patients.Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA.The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients.Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage studyDrug interactions and antiretroviral drug monitoring.Hepatitis C virus infection in the human immunodeficiency virus infected patient.Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with men.Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples.Hepatitis C virus/HIV coinfection and responses to initial antiretroviral treatment.Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C)Predictors of liver-related death among people who inject drugs in Vancouver, Canada: a 15-year prospective cohort study.HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patientsRapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologiesPredictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patientsInterleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problemsCare at the Crossroads: Navigating the HIV, HCV, and Substance Abuse Syndemic.Electronic matching of HIV/AIDS and hepatitis C surveillance registries in three states
P2860
Q26775815-E4D86DDC-84F1-4F1D-B55A-A8CEDC8D1F64Q26798469-1C99457C-730A-499C-B72C-30C37B118AF8Q26864344-583B4DFD-D8EF-43B4-AB74-2FDB30EC221FQ26864478-518110C8-D4E3-4890-9703-85CCCAAC274BQ27010548-D80D0C6B-1312-45D4-AD21-0FB8F1D18B84Q27012918-3F6B993F-0A25-4E45-9EF0-53AFF84C26DBQ27488883-228AB147-4E80-4F93-8FD4-11EB8BFBD6D1Q27490854-0610A78B-C86D-4956-8416-832790103BC0Q27491016-3CC68DD7-DD67-4ABE-83CB-0185F54A8D9DQ28084654-20457406-1B04-45BE-A998-312586E3A6B4Q28085718-7B12324B-9958-405D-8386-A2EEC93A974BQ28483820-173B3141-B06F-458F-AEC9-7B503553F7D3Q28550423-804FE4C1-8BBA-470C-92FE-FA11C276D6E4Q30209635-F173A0C9-8F4B-48E9-AB67-C3F32CE0C44AQ30241549-B5E95D22-2742-4601-BD6A-881A9D1C63C7Q30419090-2A2501FD-BF3E-4426-A5C9-CE4232C5D03BQ30751889-320CFE76-9AE6-41B5-828E-DC8E0772386AQ33391761-AB121806-5EB3-4CE3-A012-64F2C7759542Q33413051-0BC6E297-6498-42B1-85DB-9E223C2CC2E1Q33557819-50F83338-B95E-477B-ABF1-FF7DD881C692Q33585762-1D4C2E69-B6A2-4C28-8D8B-418412C3AD75Q33645965-D93F9B6F-DC82-4B2F-84D0-322A0FD994C9Q33648600-C41B3C68-34B0-46A7-91BC-D523D7D788F6Q33710740-1E54FF54-080A-4EE6-8FE5-1B31A50DFDE2Q33801743-4116F901-AC41-43BB-9351-2C6BF6724FAFQ34021173-E5F5AAED-7D29-447B-B14C-E5EC65BFB16AQ34168504-070C8E06-D14C-4384-A953-3E876AE74DDFQ34227450-92302F90-816D-47AB-BD6E-D7DACEA27A0BQ34380399-FFE52FFE-FEC6-4FF7-9D3A-0444FC5CB58EQ34427088-5D89BBFA-DD91-491F-A7FC-78EC88C0D521Q34457915-BBAFAED8-8876-430E-9A81-4EA7DA2B18B8Q34474434-E8A456F4-E8BC-4F76-B338-03D859DE947DQ34491134-3C935F98-8A67-4FA6-AD7F-47C219B18C45Q34505231-101738B0-D598-44E2-B92B-AE83FF7C1A75Q34522213-E0CEBED9-61A7-4AD7-8C32-BFCBBBAFBD97Q34561257-01E26502-333A-4C69-B188-5027AB45604DQ34634839-9A070A64-00C7-42F8-BA90-80AED6EC3574Q34677793-FC0F01BD-3542-4F82-9EE9-295938794CC4Q34702334-2A571FC4-83C9-4A7A-AD1C-75B8E107DD03Q34773912-B2A51770-B4BF-4114-9B95-9F29A571A25B
P2860
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Natural history of hepatitis C ...... iral therapy: a meta-analysis.
@en
Natural history of hepatitis C ...... iral therapy: a meta-analysis.
@nl
type
label
Natural history of hepatitis C ...... iral therapy: a meta-analysis.
@en
Natural history of hepatitis C ...... iral therapy: a meta-analysis.
@nl
prefLabel
Natural history of hepatitis C ...... iral therapy: a meta-analysis.
@en
Natural history of hepatitis C ...... iral therapy: a meta-analysis.
@nl
P31
P921
P1433
P1476
Natural history of hepatitis C ...... iral therapy: a meta-analysis.
@en
P2093
Gregory J Dore
P304
P356
10.1097/QAD.0B013E32830E6D51
P407
P577
2008-10-01T00:00:00Z